Legato Capital Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Legato Capital Management's ROIV Position: Q3 2026 in Review
Legato Capital Management reduced its Roivant Sciences (ROIV) stake by 19% in Q3 2026, selling an estimated $310K and leaving 37,430 shares worth $1.37M. The position accounts for 0.12% of the portfolio, ranked #262.
Legato Capital Management first reported a position in ROIV in Q2 2023 and has held it in 8 quarters since. The position peaked at $1.63M in Q2 2026. 522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Legato Capital Management held 37,430 shares of Roivant Sciences worth $1.37M as of Q3 2026.
- Legato Capital Management sold 8,558 Roivant Sciences shares in Q3 2026, an estimated $310K.
- Roivant Sciences made up 0.12% of Legato Capital Management's portfolio in Q3 2026, its #262 holding.
- Legato Capital Management first reported a position in Roivant Sciences in Q2 2023 and has held it in 8 quarters since.
- Legato Capital Management's Roivant Sciences position peaked at $1.63M in Q2 2026.
- 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Legato Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.